baber/WOPTO huggingface dataset:
Patent NZ-213154-A (NZ)
Title: Dna expression vector, plasmid, host vector system and production of polypeptide
Inventor: AVIV HAIM
IPC: C12N15/73
Filed: 1985-08-20
Abstract: (1) Vector that on introduction into a suitable bacterial host cell contg. the thermolabile repressor C (I) renders the host cell capable, when the temp. is raised to a level at which the repressor is inactivated, of effecting expression of a desired gene inserted in the vector to produce polypeptide (I) encoded by the gene is new when it comprises a double-stranded DNA molecule including in 5'- to 3'- order. (a) DNA sequence contg. the promoter and operator P(L)O(L) from lambda bacteriophage; (b) a N utilisation site for binding antiterminator N protein; (c) a first restriction enzyme site permitting replacement of the DNA sequence contg. the ribosomal binding site following after; (d) DNA sequence contg. a ribosomal binding site for making the MRNA of the desired gene capable of binding to ribosomes in the host cell; (e) ATG initiator codon or a DNA sequence converted into the codon on insertion of the desired gene into the vector; and (f) a second restriction enzyme site for inserting the desired gene into the vector in phase with the ATG initiation codon; and (g) a DNA sequence contg. an origin of replication from a bacterial plasmid capable of autonomous replication in the host cell; and for selection, DNA sequence contg. a gene associated with a selectable or identifiable phenotypic trait manifested when the vector is present in the host cell, or DNA sequence contg. fragment C (I) 434, including the gene for the C (I) 434 repressor protein and its associated promoter and operator sequence.
Patent NZ-216050-A (NZ)
Title: Bromocriptine compositions for treating psychostimulant addiction
Inventor: DACKIS C A
IPC: A61K/
Filed: 1986-05-05
Abstract: Dopamine agonists for the treatment of psychostimulant addiction.
Patent NZ-234296-A (NZ)
Title: Separation of isomers of 4-hydroxymethyl dioxolane using a microorganism which consumes the r-isomer
Inventor: DE SMET MARIE JOSE
IPC: C07D317/20
Filed: 1990-06-28
Abstract: Process for the preparation of S-2,2-R1,R2-1,3-dioxolane-4-methanol wherein R1 and R2 are each independently H or an alkyl group or wherein R1 and R2 together with the carbon atom to which they are attached form a carbocyclic ring by subjecting a mixture of R- and S-2,2-R1,R2-1,3-dioxolane-4-methanol to the action of a microorganism or substance derived therefrom which is capable of stereoselective consumption of R-2,2-R1,R2-1,3-dioxolane-4-methanol preferably until at least 50 wt% of the R-2,2-R1,R2-1,3-dioxolane-4-methanol is consumed. Various microorganisms are disclosed as suitable for the purpose.
Patent NZ-236175-A (NZ)
Title: Isoindole derivatives and their preparation
Inventor: DUBROEUCQ MARIE-CHRISTINE
IPC: A61P27/14
Filed: 1990-11-21
Abstract: New isoindolone derivatives of general formula (I) are   <IMAGE> (I) disclosed in which the radicals R represent hydrogen atoms or, together, form a bond, the symbol R' represents a hydrogen atom or a readily removable radical and the symbols R'' are identical and represent phenyl radicals which can be substituted with a halogen atom or a methyl radical at the ortho or meta position, in the (3aR, 7aR) form or in the form of a mixture of the (3aRS, 7aRS) forms, as well as their salts. These derivatives are useful as intermediates for the preparation of therapeutically active products.
Patent NZ-246376-A (NZ)
Title: Formulation and use of microorganisms in promoting growth of livestock
Inventor: MANN STEPHEN PHILIP
IPC: A61K35/742
Filed: 1993-01-13
Abstract: PCT No. PCT/GB93/00065 Sec. 371 Date Jul. 13, 1994 Sec. 102(e) Date Jul. 13, 1994 PCT Filed Jan. 13, 1993 PCT Pub. No. WO93/13786 PCT Pub. Date Jul. 22, 1993For therapeutic use, and particularly for promoting growth or weight gain in livestock under intensive husbandry, a formulation comprises a first microorganism capable of producing lactic acid in the gastrointestinal tract of the animal and a second microorganism capable of producing a bactericide to which the microorganisms are resistant. The formulation may also comprise the means for digesting fiber and/or lactoperoxidase.
Patent NZ-269375-A (NZ)
Title: Chromatographic method of purifying complement receptor protein
Inventor: SMITH THOMAS MICHAEL
IPC: C07K1/20
Filed: 1994-07-06
Abstract: PCT No. PCT/US94/07555 Sec. 371 Date Apr. 3, 1996 Sec. 102(e) Date Apr. 3, 1996 PCT Filed Jul. 6, 1994 PCT Pub. No. WO95/01797 PCT Pub. Date Jan. 19, 1995This invention relates to the application of immobilized metal affinity chromatography to the purification of complement receptor proteins.
Patent NZ-279062-A (NZ)
Title: Use of phenylazosalicylic acid derivatives for treatment/prevention of colon cancer
Inventor: JOHNSON LORIN K
IPC: A61K31/60
Filed: 1995-01-06
Abstract: Disclosed is a method of manufacturing a medicament for the treatment of colon cancer chemoprevention or chemotherapy. The pharmaceutical composition comprises an effective amount of a 2-hydroxy-5-phenylazobenzoic acid derivative or an ester of an active metabolite or an oxidation product of an active metabolite thereof, or a pharmacologically acceptable salt of the 2-hydroxy-5-phenylazobenzoic acid derivative or an ester or an active metabolite or an oxidation product of an active metabolite thereof.
Patent NZ-286360-A (NZ)
Title: Condensed pyridine derivatives and medicaments thereof
Inventor: VIAUD MARIE-CLAUDE
IPC: A61K31/435
Filed: 1996-04-12
Abstract: Furo-, thieno- or pyrrolo-pyridine derivs. of formula (I), and their isomers and salts are new. X = O, S or NR7; R1-R4 = H, halo, OH, Ra or ORa; Ra = alkyl, haloalkyl, trialkylsilyl, alkenyl, alkynyl, cycloalkyl, cycloalkylalkyl, or opt. substd. aryl or arylalkyl; either R5 = -A-B-Y; and R7 = H, alkyl, or opt. substd. aryl or arylalkyl; or R7 = -A-B-Y and R5 = as for R1-R4; A = 1-6C alkylene opt. substd. by one or more alkyl gps.; B = -NR6-C(=Z)- (B1), -NR6-C(=Z)-NH- (B2) or -C(=Z)-NR6- (B3); Y = H or Y1, but not H when B = B3; Y1 = alkyl, haloalkyl, alkenyl, alkynyl, cycloalkyl or cycloalkylalkyl; Z = O or S; R6 = H, alkyl, cycloalkyl, cycloalkylalkyl, aryl or arylalkyl; provided that: (a) (I) is not N-(2-(1H-pyrrolo Ä3,2-cÜ pyridin-3-yl) ethyl)- acetamide; and (b) R7 is not phenyl when the N atom of the pyridine ring is in position 7 of the heterocycle, R1 = alkyl in position 4 of the heterocycle, and R2-R4 = H; alkyl, alkoxy = 1-6C; alkenyl, alkynyl = 2-6C; cycloalkyl = 3-8C; aryl = phenyl, naphthyl or pyridyl; substd. aryl or arylalkyl has one or more substits. selected from halogen, alkyl, alkoxy, OH and haloalkyl.
Patent NZ-287445-A (NZ)
Title: Pharmaceutical composition comprising (s)-2-(4-isobutylphenyl)propionic acid and microcrystalline cellulose and colloidal silica excipients
Inventor: STROPPOLO FEDERICO
IPC: A61K47/02
Filed: 1995-05-26
Abstract: PCT No. PCT/EP95/02010 Sec. 371 Date Nov. 27, 1996 Sec. 102(e) Date Nov. 27, 1996 PCT Filed May 26, 1995 PCT Pub. No. WO95/35104 PCT Pub. Date Dec. 28, 1995The present invention relates to a solid pharmaceutical composition containing (S)-2-(4-isobutylphenyl) propionic acid as active ingredient and it relates to a solid pharmaceutical composition suitable for the preparation of pharmaceutical forms in tablets, sachets and capsules containing (S)-2-(4-isobutylphenyl)-propionic acid as active ingredient. This formulation in tablets contains (S)-Ibupropen, colloidal silica as disintegrating agent, microcrystalline cellulose as diluent and magnesium stearate as lubricant. Tablets are prepared by direct compression of the pharmaceutical composition object of the present invention and may be coated or filmed according to conventional techniques.
Patent NZ-303534-A (NZ)
Title: Overcap sprayer assembly
Inventor: DEMAREST SCOTT W
IPC: B65D83/40
Filed: 1996-02-13
Abstract: An overcap sprayer assembly and method of its manufacture. The overcap sprayer assembly includes an actuator and an overcap. The actuator has a body and a sprayer arm. The body attaches preferably to the valve cup rim of the can. A skirt extends circumferentially around the perimeter of the body. At least one actuator access port provides access through the skirt to the interior of the body. The sprayer arm of the actuator has a nozzle adapted to direct spray outwardly through an actuator access port. The overcap attaches to the skirt of the actuator body in coaxially turning relation thereto. An overcap wall extends downwardly from the outer margins of the overcap dome, surrounding the actuator body. The overcap also has at least one overcap access port that may be moved between an open position, wherein an overcap access port is aligned with the actuator access port through which the nozzle is adapted to direct spray, and a closed position, wherein the overcap wall obstructs the actuator access port. Preferably a lock member extends from one of the actuator body and the overcap to project into and engage an opposed locking port of the other of the actuator body and overcap. Preferably the locking port is an access port. The lock member has an unlocked position, wherein it is not engaged in an opposed locking port and the overcap may freely turn on the actuator body, and a locked position assumed when the lock member becomes aligned with an opposed locking port, projects thereinto, and engages the opposed locking port, resisting further overcap turning.
Patent NZ-331445-A (NZ)
Title: 3,4-Disubstituted phenylethanolaminotetralincarboxamide derivatives
Inventor: KITAZAWA MAKIO
IPC: C07D295/185
Filed: 1997-02-18
Abstract: 3,4-Disubstituted phenylethanolaminotetralincarboxamide derivatives represented by general formula (I) and their pharmacologically acceptable salts having a selective 'beta'2-adrenergic receptor stimulating effect with a relieved burden on the heart such as frequent pulse. In said formula, A represents lower alkylene; B represents amino, di(lower alkyl)amino or 3- to 7-membered alicyclic amino optionally containing oxygen in the ring; n is an integer of 1 or 2; the carbon atom marked with "*" means a carbon atom or the R- or S- configuration or a mixture thereof; and the carbon atom marked with "(S)" means a carbon atom of the S-configuration. These compounds are useful as a preventive for threatened abortion/premature birth, a bronchodilator and a pain-relieving and lithagogue agent in ureterolithiasis.
Patent NZ-333722-A (NZ)
Title: Soluble fatty acid derived peptide each with binding element more than 5kD as medicaments for disorders associated with inflammation or inappropriate complement activation
Inventor: SMITH RICHARD ANTHONY GODWIN
IPC: A61K47/48
Filed: 1997-07-08
Abstract: A soluble derivative of a soluble polypeptide, said derivative comprising two or more heterologous membrane binding elements with low membrane affinity covalently associated with the polypeptide, which elements are not all identical and are capable of interacting, independently and with thermodynamic additivity, with components of cellular or artificial membranes exposed to extracellular fluids. Preferred membrane-binding elements are fatty acid derivatives or polylysine-containing sequences.
Patent NZ-335155-A (NZ)
Title: Telephone system with number portability, exchanges connected to subscriber location server
Inventor: KALLIONIEMI KARL-ERIK
IPC: H04Q3/545
Filed: 1997-10-17
Abstract: In a telephone system, number portability is effected by the use of a subscriber location server 30.  The subscriber location server stores a database of subscriber numbers and a corresponding network routing prefix (NRP).  The NRP is a node identifier for the local exchange to which the called subscriber is connected.  When a call is made, the caller's local exchange determines whether the called number is one that is part of the number portability scheme.  If it is, then the subscriber location server is interrogated to find the NRP, which is transmitted back to the local exchange.  The NRP and called subscriber number are concatenated, and the combination replaces the address signal field of a called party parameter, so that the call can be routed to the correct exchange.  If a subscriber relocates, then the database in the subscriber location server is updated so that the NRP is that of the local exchange to which the subscriber is now connected.  Subscribers can therefore use the same number regardless of actual location.
Patent NZ-337720-A (NZ)
Title: Plant genes for sensitivity to ethylene and pathogens
Inventor: ECKER JOSEPH
IPC: A01H1/04
Filed: 1998-03-18
Abstract: Nucleic acid sequences for ethylene insensitive, EIN loci and corresponding amino acid sequences.
Patent NZ-337731-A (NZ)
Title: Roof vents for greenhouse, has steeper pitch than rafters
Inventor: EDWARDS CHRISTOPHER
IPC: A01G9/18
Filed: 1999-09-08
Abstract: This greenhouse comprises raised ridges, where each raised ridge has at least one bracket extending upward from the apex of the roof of the greenhouse, and each bracket has one or vents attached thereto such that in a closed position the vent has a greater pitch than the roof.
Patent NZ-501911-A (NZ)
Title: Lactoferrin receptor genes (Lbp1, Lbp2 and/or ORF3) of Moraxella to be used in diagnosis or treatment of Moraxella related diseases such conjunctivitis, sinusitis or urogenital infections
Inventor: DU RUN-PAN
IPC: A61K38/00
Filed: 1998-06-02
Abstract: Purified and isolated nucleic acid molecules are provided which encode lactoferrin receptor proteins of Moraxella, such as M. catarrhalis, or a fragment or an analogue of the lactoferrin receptor protein. The nucleic acid sequence may be used to produce recombinant lactoferrin receptor proteins Lbp1, Lbp2 and ORF3 of the strain of Moraxella free of other proteins of the Moraxella strain for purposes of diagnostics and medical treatment. Furthermore, the nucleic acid molecule may be used in the diagnosis of infection.
Patent NZ-503764-A (NZ)
Title: Post, typically fence strainer post, with stabilising leg or legs pivoted and slidable relative to post
Inventor: YOUNG TIMOTHY WILLIAM
IPC: E04H17/22
Filed: 2000-04-04
Abstract: A support post including a main post with one or more adjustable legs attached thereto via retaining means where: 1.	the retaining means is adapted in a first unsecured position to be movable along the main post and is adapted in a second secured position to be fixed at a predetermined position on the main post, and 2.	the retaining means is further adapted to allow each of the one or more adjustable legs to be moveable between a first closed position in which each leg lies substantially adjacent the main post and a second open position in which each leg is spaced apart from the main post.
Patent NZ-505758-A (NZ)
Title: Dual function dispenser with active and passive dispensers
Inventor: FURNER PAUL E
IPC: B65D83/14
Filed: 2000-07-14
Abstract: A dispenser for dispersible materials having at least two separate and independent sources of dispersible material comprises the combination of: a) at least one active dispenser for an actively dispersible material comprising a reservoir containing the actively dispersible material and means to dispense the actively dispersible material from the reservoir to the atmosphere and b) at least one independent passive dispenser for a volatile dispersible material comprising a second reservoir containing the volatile dispersible material which is  separate from the first reservoir and means to control volatilization of the volatile dispersible material with the dispenser package encompassing the active and passive dispensers and comprising a decorative body having a passage therein for dispensing the actively dispersible material from at least one active dispenser and openings therein for passively dispensing the volatile dispersible material.  The actively dispersible material and the volatile dispersible material are individually and independently dispensable.
Patent NZ-516873-A (NZ)
Title: Compositions containing retinoids and erb inhibitors and their use in inhibiting retinoid skin damage
Inventor: ELDER JAMES TILFORD
IPC: A61K45/00
Filed: 2002-01-28
Abstract: A composition of a retinoid and an erb inhibitor. The retinoid is selected from all-trans-retinal, all-trans retinal, all-trans retinoic acid, 9-cis retinoic acid, 13- cis-retinoic acid, 13-cis-retinal, 13-cis-retinol, 9-cis- retinal or 9-cis-retinol. The erb inhibitor is a quinazoline or a pyridopyrimidine. The composition may be used in treating skin disorders such as photoaging, acne, psoriasis, precancerous lesions of the skin or skin cancer.
Patent NZ-517411-A (NZ)
Title: N-heterocyclic derivatives as NOS inhibitors
Inventor: ARNAIZ DAMIAN O
IPC: A61P21/00
Filed: 2000-08-24
Abstract: Compounds of formulas (Ya), (Yb) and (Yc) wherein  R1, R2,  R4,  R5,  m, n, A and W are as described  in  claim  1. Also  described  are pharmaceutical compositions  containing these   compounds  and  their  use  in  the   treatment   of conditions  resulting  from an abnormality  in  nitric  acid production.
Patent NZ-518425-A (NZ)
Title: Fused pyrimidin-4-one compounds useful as 5-HT2c and alpha2-AR inhibitors
Inventor: LAVIELLE GILBERT
IPC: A61P25/20
Filed: 2002-04-17
Abstract: Fused pyrimidin-4-one compounds if formula (1) their enantiomers, diastereoisomers, addition salts that are useful as 5-HT2c and a2-AR inhibitors, a process for their preparation and pharmaceutical compositions containing them are disclosed, wherein: R1, R2, R3 & R4 which may be same or different, each represent H, halogen, linear or branched C1-C6alkyl, linear or branched C1-C6alkoxy, linear or branched C1-C6polyhaloalkyl, cyano, nitro or amino, or R1 with R2, R2 with R3, or R3 with R4 together with the carbon atom carrying them form an optionally substituted benzene ring; X is O or -CH3; A is linear or branched C1-C6alkylen chain; B shown as a ring with N represents an unsaturated nitrogen-containing heterocycle optionally substituted by one or two identical or different substituents selected from a halogen, linear or branched C1-C6alkyl, hydroxy, linear or branched C1-C6alkoxy,  linear or branched C1-C6polyhaloalkyl, cyano, nitro or amino, optionally substituted phenyl, optionally substituted thienyl, optionally substituted furyl or optionally substituted pyrrolyl group; and R5 is linear or branched C1-C6alkyl.
Patent NZ-521248-A (NZ)
Title: Cyclic beta-amino acid derivatives as inhibitors of matrix metalloproteases and TNF-alpha
Inventor: DUAN JINGWU
IPC: C07D405/12
Filed: 2001-03-15
Abstract: Compounds of formula I, wherein A is -CONHOH; B is a 3-13 membered non-aromatic carbocyclic or heterocyclic ring comprising carbon atoms, 0-3 carbonyl groups, 0-4 double bonds, and from 0-2 ring heteroatoms selected from O, N, NR2, and S(O)p; and the remaining substituents are defined herein. The compounds are used in the manufacture of medicaments as inhibitors of matrix metalloproteases and TNF-alpha .
Patent NZ-522148-A (NZ)
Title: A holder for a fire extinguisher
Inventor: ALBERTS FREDERICK WILLIAM
IPC: A62C13/78
Filed: 2001-04-03
Abstract: Article holder comprises seat member shaped to receive article, gate member hingedly coupled to seat member, gate member shaped to cooperate with the seat member in a closed position so as to grasp article. A rotatable handle is connected with the gate member so as to move gate member between open position and closed position as handle is rotated. The handle has locking means for locking the handle when the handle is rotated to a lock position, wherein the handle must be over rotated further than the position where the gate member is closed to be positioned in lock position. Over rotation causes compressive gripping force to gate member such that the gate member continues to grasp article with the handle in the lock position.
Patent NZ-522488-A (NZ)
Title: Peelable foam coating composition comprising an aqueous film forming composition, release agent, propellant, thickening agent surfactant antioxidant and a profoamer
Inventor: ZHANG ZHIQIANG
IPC: C09D5/20
Filed: 2001-03-23
Abstract: Described are water resistant peelable protective and decorative clear or pigmented foam coating compositions and, more specifically, aqueous and solvent based, polymeric coating compositions which form a protective and/or decorative coating and is removably adhered to a variety of substrates, including automotive paints, metals, glass, vinyl, plastics, concrete, natural and synthetic plasterers, and ceramics. The coatings present a three-dimensional expandable foamy coating, and can be readily peeled off from the substrate as a whole piece. The coatings may be formulated for temporary or long-term protection depending upon the application. The peelable coatings can be applied as a paint, paste, film, or expandable foam cord whereby the expansion of the foam can be controlled by the formulation and applicator.
Patent NZ-529008-A (NZ)
Title: Rope of synthetic fibre with reinforcement element for frictionally engaged power transmission and rope of synthetic fibre with reinforcement element for positively engaged power transmission
Inventor: EICHHORN ROLAND
IPC: D07B5/00
Filed: 2003-10-20
Abstract: The rope of synthetic fiber (30) comprises two popes (31, 32) from synthetic fiber strands (35-37), which are arranged for the taking up of force in a lengthwise direction. The ropes (31, 32) are arranged along the lengthwise direction of the rope of synthetic fiber (30) with a distance to each other and are fixed by means of a rope sheathing (33). The rope sheathing (33) exhibits a fixed link, running in the lengthwise direction of the rope of synthetic material (30), between the two ropes (31, 32). The rope of synthetic fiber (30) comprises of at least one reinforcement element (34) for mechanical reinforcement of the rope sheathing (33).
Patent NZ-530573-A (NZ)
Title: Compositions and methods for the modification of gene transcription
Inventor: WOOD MARION
IPC: C12N15/09
Filed: 2000-03-09
Abstract: An isolated polynucleotide that encodes plant transcription factors can comprise the sequence of SEQ ID NOs:120, 124, 170, 171, 219, 220, 224, 226, 229, 230, 238, 242, 243, 245, 247, 256, 301, 320, 330, 432, 434, 435, 436, 445, 447, 451, 453, 454, 459, 466, 469, 476, 481, 490, 524, 546, 570 or 1895. Also described is the polypeptide that is encoded by the polynucleotide and plants cells transformed with a DNA construct comprising the polynucleotide.
Patent NZ-533364-A (NZ)
Title: Flexible plastic container with recesses in inner walls to assist vacuum evacuation
Inventor: WILFORD MICHAEL
IPC: B65D77/06
Filed: 2002-11-12
Abstract: A flexible polymeric container 10 for storing and dispensing liquids includes a first sidewall 12 and a second sidewall 13 connected together to define a fluid chamber 16 therebetween. The first sidewall 12 and the second sidewall 13 each have an inner surface facing the fluid chamber 16 and opposed to the outer surface. A fitment 18 is attached to an outer surface of one of the first sidewall 12 or the second sidewall 13. The fitment 18 has an opening therethrough which has an axis substantially perpendicular to the outer surface. A plurality of objects 20 on the inner surface of one of the first sidewall 12 or the second sidewall 13 defines a plurality of pathways 32, 33 having at least a first pathway 32 and a second pathway 33 intersecting one another. The first and second pathways each have a depth of greater than 1 mil but less that 8 mils.
Patent NZ-534374-A (NZ)
Title: Method of synthesizing camptothecin-relating compounds
Inventor: OGAWA TAKANORI
IPC: C07C205/45
Filed: 2003-08-14
Abstract: A process for preparing 2'-amino-5'hydroxypropiophenone to synthesize camptothecin analogs as depicted in the diagram as disclosed, where R is a protective group which can be deprotected by a catalytic reduction. Camptothecin analogs such as 7-ethyl-10-hydroxycamptothecin are key intermediates in synthesis of irinotecan, a type of anti-cancer topoisomerase inhibitor. (62) Divided out of 527615